| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |